These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15578952)

  • 61. [Effect of nuclear factor-kappa B decoy oligodeoxynucleotides on IL-10, IL-13 and nuclear factor-kappa B protein expressions in rabbits with severe lung contusion].
    Fang DQ; Yu T; Wan L
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2284-7. PubMed ID: 20965826
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transcription factor decoy for nuclear factor-kappaB inhibits tumor necrosis factor-alpha-induced expression of interleukin-6 and intracellular adhesion molecule-1 in endothelial cells.
    Tomita N; Morishita R; Tomita S; Yamamoto K; Aoki M; Matsushita H; Hayashi S; Higaki J; Ogihara T
    J Hypertens; 1998 Jul; 16(7):993-1000. PubMed ID: 9794740
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Transcription factor oligodeoxynucleotides to NF-kappaB inhibit transcription of IL-8 in bronchial cells.
    Bezzerri V; Borgatti M; Nicolis E; Lampronti I; Dechecchi MC; Mancini I; Rizzotti P; Gambari R; Cabrini G
    Am J Respir Cell Mol Biol; 2008 Jul; 39(1):86-96. PubMed ID: 18258920
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Effects of nuclear factor of kappa B decoy oligodeoxynucleotides on murine with multiple myeloma].
    Shi KH; Jiang HL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):132-6. PubMed ID: 25687060
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inhibition of ets, an essential transcription factor for angiogenesis, to prevent the development of abdominal aortic aneurysm in a rat model.
    Miwa K; Nakashima H; Aoki M; Miyake T; Kawasaki T; Iwai M; Oishi M; Kataoka K; Ohgi S; Ogihara T; Kaneda Y; Morishita R
    Gene Ther; 2005 Jul; 12(14):1109-18. PubMed ID: 15800662
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Transcription factor decoy oligodeoxynucleotides to nuclear factor-kappaB inhibit reverse passive Arthus reaction in rat.
    D'Acquisto F; Ianaro A; Ialenti A; Maffia P; Maiuri MC; Carnuccio R
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):422-9. PubMed ID: 11692225
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Enhanced intracellular uptake and inhibition of NF-kappaB activation by decoy oligonucleotide released from PLGA microspheres.
    De Rosa G; Maiuri MC; Ungaro F; De Stefano D; Quaglia F; La Rotonda MI; Carnuccio R
    J Gene Med; 2005 Jun; 7(6):771-81. PubMed ID: 15702489
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cell death in NF-kappaB-dependent tumour cell lines as a result of NF-kappaB trapping by linker-modified hairpin decoy oligonucleotide.
    Laguillier C; Hbibi AT; Baran-Marszak F; Metelev V; Cao A; Cymbalista F; Bogdanov A; Fagard R
    FEBS Lett; 2007 Mar; 581(6):1143-50. PubMed ID: 17328896
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular therapy via transcriptional regulation with double-stranded oligodeoxynucleotides as decoys.
    Nakamura H; Morishita R; Kaneda Y
    In Vivo; 2002; 16(1):45-8. PubMed ID: 11980360
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Regulation of NF-kappaB signaling by decoy oligodeoxynucleotides.
    Isomura I; Morita A
    Microbiol Immunol; 2006; 50(8):559-63. PubMed ID: 16924140
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Locked nucleic acids (LNA): versatile tools for designing oligonucleotide decoys with high stability and affinity.
    Crinelli R; Bianchi M; Gentilini L; Palma L; Magnani M
    Curr Drug Targets; 2004 Nov; 5(8):745-52. PubMed ID: 15578954
    [TBL] [Abstract][Full Text] [Related]  

  • 72. E2F decoy oligodeoxynucleotide ameliorates cartilage invasion by infiltrating synovium derived from rheumatoid arthritis.
    Tomita T; Kunugiza Y; Tomita N; Takano H; Morishita R; Kaneda Y; Yoshikawa H
    Int J Mol Med; 2006 Aug; 18(2):257-65. PubMed ID: 16820932
    [TBL] [Abstract][Full Text] [Related]  

  • 73. New trends in the development of transcription factor decoy (TFD) pharmacotherapy.
    Gambari R
    Curr Drug Targets; 2004 Jul; 5(5):419-30. PubMed ID: 15216908
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial.
    Mann MJ; Whittemore AD; Donaldson MC; Belkin M; Conte MS; Polak JF; Orav EJ; Ehsan A; Dell'Acqua G; Dzau VJ
    Lancet; 1999 Oct; 354(9189):1493-8. PubMed ID: 10551494
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation.
    Lenert P; Stunz L; YI AK; Krieg AM; Ashman RF
    Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):247-56. PubMed ID: 11572601
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Advantages of the circular dumbbell decoy in gene therapy and studies of gene regulation.
    Lee IK; Ahn JD; Kim HS; Park JY; Lee KU
    Curr Drug Targets; 2003 Nov; 4(8):619-23. PubMed ID: 14577652
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Decoy oligodeoxyribonucleotides and peptide nucleic acids-DNA chimeras targeting nuclear factor kappa-B: inhibition of IL-8 gene expression in cystic fibrosis cells infected with Pseudomonas aeruginosa.
    Gambari R; Borgatti M; Bezzerri V; Nicolis E; Lampronti I; Dechecchi MC; Mancini I; Tamanini A; Cabrini G
    Biochem Pharmacol; 2010 Dec; 80(12):1887-94. PubMed ID: 20615393
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Local administration of transcription factor decoy oligonucleotides to nuclear factor-kappaB prevents carrageenin-induced inflammation in rat hind paw.
    D'Acquisto F; Ialenti A; Ianaro A; Di Vaio R; Carnuccio R
    Gene Ther; 2000 Oct; 7(20):1731-7. PubMed ID: 11083494
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antitumor activity of decoy oligodeoxynucleotides targeted to NF-kappaB in vitro and in vivo.
    Wang T; Li QH; Hao GP; Zhai J
    Asian Pac J Cancer Prev; 2010; 11(1):193-200. PubMed ID: 20593956
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Transcription factor decoy for NFkappaB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis.
    Tomita T; Takano H; Tomita N; Morishita R; Kaneko M; Shi K; Takahi K; Nakase T; Kaneda Y; Yoshikawa H; Ochi T
    Rheumatology (Oxford); 2000 Jul; 39(7):749-57. PubMed ID: 10908694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.